January 1, 2015EuroIntervention
Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry
Why the study?
Does the severity of chronic kidney disease impact 30-day and one-year mortality in patients undergoing TAVI?
Population
2,929 consecutive patients undergoing transcatheter aortic valve implantation from the FRANCE 2 registry…
Comparison
Transcatheter aortic valve implantation in… vs Transcatheter aortic valve implantation in…
Design
Cohort
Follow-up
1 year
Authors
Discussion
Loading...
Member takes
Implication
May support CKD staging for TAVI risk stratification; leaves open whether targeted interventions improve survival.
Structured PICO
Does the severity of chronic kidney disease impact 30-day and one-year mortality in patients undergoing TAVI?
P
Population
2,929 consecutive patients undergoing transcatheter aortic valve implantation (TAVI) from the FRANCE 2 registry, stratified by chronic kidney disease (CKD) stages 1+2, 3a, 3b, 4, and 5.
I
Intervention
Transcatheter aortic valve implantation (TAVI) in patients with advanced CKD (stages 3a, 3b, 4, and 5)
C
Comparator
Transcatheter aortic valve implantation (TAVI) in patients with mild or no CKD (stages 1+2)
O
Outcome
30-day and one-year mortalityhard clinical
Pre-procedural CKD staging effectively stratifies risk in TAVI patients, with stages 3b, 4, and 5 correlating with significantly poorer 30-day and 1-year outcomes.
Cite This Study
Oguri et al. (2015) studied this question.